Published in Gut Microbes on January 01, 2014
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol (2016) 1.03
Clostridium difficile infection. Nat Rev Dis Prim (2016) 0.99
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
CdtR Regulates TcdA and TcdB Production in Clostridium difficile. PLoS Pathog (2016) 0.87
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance. Genes (Basel) (2015) 0.84
Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Front Immunol (2017) 0.81
Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis. PLoS One (2016) 0.76
Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate. Antimicrob Agents Chemother (2015) 0.76
Determining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases. BMC Microbiol (2017) 0.75
Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains. PLoS One (2016) 0.75
Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model. Front Microbiol (2017) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet (2006) 8.02
Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
The role of toxin A and toxin B in Clostridium difficile infection. Nature (2010) 5.32
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis (2007) 4.77
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet (2001) 4.59
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods (2007) 4.20
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol (2007) 4.09
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
S-Layer proteins. J Bacteriol (2000) 3.64
Structure, assembly, and function of the spore surface layers. Annu Rev Microbiol (2007) 3.50
Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett (2000) 3.50
Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol (2008) 3.37
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol (2002) 3.26
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene (1996) 2.87
Muramic lactam in peptidoglycan of Bacillus subtilis spores is required for spore outgrowth but not for spore dehydration or heat resistance. Proc Natl Acad Sci U S A (1996) 2.75
Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res (2007) 2.67
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60
Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun (1997) 2.42
Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog (2009) 2.29
Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol (2008) 2.25
Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun (1987) 2.06
Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol (2007) 2.05
Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev (2008) 2.04
Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis (2013) 2.03
The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun (2012) 2.02
Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00
Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis (2006) 1.99
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis (2010) 1.97
Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J Bacteriol (2009) 1.96
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut (1986) 1.93
Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control (2010) 1.91
Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology (2003) 1.91
Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol (2007) 1.90
Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A (2001) 1.89
Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis (2006) 1.85
Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology (2010) 1.83
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol (2010) 1.82
Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis (2011) 1.79
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol (2010) 1.73
Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol (2009) 1.71
Evolution of signalling in the sporulation phosphorelay. Mol Microbiol (2002) 1.71
Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol (2012) 1.70
The morphology and ultrastructure of the spore and exosporium of some Clostridium species. J Gen Microbiol (1967) 1.68
Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol (2005) 1.67
Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs? J Clin Microbiol (2008) 1.66
Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol (2011) 1.65
Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun (2001) 1.64
A new strategy for the prevention of Clostridium difficile infection. J Infect Dis (2013) 1.62
Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect (2007) 1.56
Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog (2013) 1.55
Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun (2002) 1.55
Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun (2001) 1.54
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol (2012) 1.47
Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS One (2010) 1.47
GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology (2001) 1.45
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect (2011) 1.45
Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc Natl Acad Sci U S A (2010) 1.44
Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes (2013) 1.41
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog (2011) 1.39
Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A. J Biol Chem (2009) 1.39
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med (2011) 1.38
Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc Natl Acad Sci U S A (2006) 1.35
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology (2007) 1.35
Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol (2010) 1.32
Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A (2011) 1.31
A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein. Mol Microbiol (2009) 1.30
Actin as target for modification by bacterial protein toxins. FEBS J (2011) 1.29
Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol (2007) 1.29
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Cellular uptake of the Clostridium perfringens binary iota-toxin. Infect Immun (2001) 1.26
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol (2008) 1.26
Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog (2010) 1.26
Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease. J Infect Dis (2012) 1.25
Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet (2013) 1.24
Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Infect Immun (2011) 1.24
Sporulation studies in Clostridium difficile. J Microbiol Methods (2011) 1.23
Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-/- embryos at 12.5 to 14.5 days of gestation. Eur J Biochem (2004) 1.23
Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics (2005) 1.22
Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture. Mol Microbiol (1993) 1.22
Surface layers of Clostridium difficile endospores. J Bacteriol (2011) 1.22
Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity. Infect Immun (2007) 1.22
A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun (2012) 1.22
Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis (2012) 1.21
Patterns of sequence conservation in the S-Layer proteins and related sequences in Clostridium difficile. J Bacteriol (2002) 1.20
Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol (2008) 1.20
Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun (2001) 1.20
Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J Biol Chem (2008) 1.19
Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infect Immun (2007) 1.18
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol (2000) 1.18
Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol (2007) 1.17
The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet (2013) 1.14
Type IV pili in Gram-positive bacteria. Microbiol Mol Biol Rev (2013) 1.14
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods (2007) 4.20
Construction and analysis of chromosomal Clostridium difficile mutants. Mol Microbiol (2006) 2.65
Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol (2002) 1.53
Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens. J Bacteriol (2006) 1.39
Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia. Med J Aust (2011) 1.38
The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes (2010) 1.37
The alpha-toxin of Clostridium septicum is essential for virulence. Mol Microbiol (2005) 1.32
Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol (2007) 1.29
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. Am J Physiol Gastrointest Liver Physiol (2004) 1.21
The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Infect Immun (2010) 1.20
Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. Lab Invest (2007) 1.18
The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol (2011) 1.14
Programmed cellular necrosis mediated by the pore-forming alpha-toxin from Clostridium septicum. PLoS Pathog (2009) 1.09
Novel molecular type of Clostridium difficile in neonatal pigs, Western Australia. Emerg Infect Dis (2013) 1.08
Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum. PLoS Pathog (2008) 1.07
The conjugation protein TcpC from Clostridium perfringens is structurally related to the type IV secretion system protein VirB8 from Gram-negative bacteria. Mol Microbiol (2011) 1.07
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun (2007) 1.07
The NanI and NanJ sialidases of Clostridium perfringens are not essential for virulence. Infect Immun (2009) 1.02
Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery (2003) 1.02
Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile. PLoS One (2013) 0.99
TcsL is an essential virulence factor in Clostridium sordellii ATCC 9714. Infect Immun (2011) 0.95
DNA binding properties of TnpX indicate that different synapses are formed in the excision and integration of the Tn4451 family. Mol Microbiol (2004) 0.94
Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe (2011) 0.93
Pore-forming activity of alpha-toxin is essential for clostridium septicum-mediated myonecrosis. Infect Immun (2009) 0.89
The peptidoglycan hydrolase TcpG is required for efficient conjugative transfer of pCW3 in Clostridium perfringens. Plasmid (2012) 0.89
Identification of essential residues in the Erm(B) rRNA methyltransferase of Clostridium perfringens. Antimicrob Agents Chemother (2002) 0.88
TcdB or not TcdB: a tale of two Clostridium difficile toxins. Future Microbiol (2011) 0.88
Identification of the structural and functional domains of the large serine recombinase TnpX from Clostridium perfringens. J Biol Chem (2004) 0.88
Small animal models for the study of Clostridium difficile disease pathogenesis. FEMS Microbiol Lett (2014) 0.88
Two distinct regions of the large serine recombinase TnpX are required for DNA binding and biological function. Mol Microbiol (2006) 0.87
Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J Antimicrob Chemother (2003) 0.86
Cross-complementation of Clostridium perfringens PLC and Clostridium septicum alpha-toxin mutants reveals PLC is sufficient to mediate gas gangrene. Microbes Infect (2009) 0.84
Emergence of toxin A-negative, toxin B-positive Clostridium difficile strains: epidemiological and clinical considerations. Future Microbiol (2015) 0.84
The cysteine protease α-clostripain is not essential for the pathogenesis of Clostridium perfringens-mediated myonecrosis. PLoS One (2011) 0.84
The Clostridium perfringens TetA(P) efflux protein contains a functional variant of the Motif A region found in major facilitator superfamily transport proteins. Microbiology (2004) 0.81
Novel use of tryptose sulfite cycloserine egg yolk agar for isolation of Clostridium perfringens during an outbreak of necrotizing enterocolitis in a neonatal unit. J Clin Microbiol (2010) 0.78
Utility of the clostridial site-specific recombinase TnpX to clone toxic-product-encoding genes and selectively remove genomic DNA fragments. Appl Environ Microbiol (2014) 0.78
Regulation of toxin production in the pathogenic clostridia. Mol Microbiol (2014) 0.77
Methods for gene cloning and targeted mutagenesis. Methods Mol Biol (2010) 0.76
Necrotic Enteritis in Chickens Associated with Clostridium sordellii. Avian Dis (2015) 0.76
Uncertainties in managing myocardial infarction associated with infective endocarditis. Exp Clin Cardiol (2012) 0.75
Solution structure and DNA binding of the catalytic domain of the large serine resolvase TnpX. J Mol Recognit (2015) 0.75
Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria. Org Biomol Chem (2015) 0.75
Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics. Org Biomol Chem (2015) 0.75
International Society for Plasmid Biology. Plasmid (2015) 0.75